ADMA Competitors & Alternatives
Compare ADMA Biologics Inc with similar stocks in the same industry
Biotechnology
ADMA
Main Stock$8.38
Tradestie Score
51
Market Cap
$3.59B
P/E Ratio
12.2
Revenue Growth
0.2%
Analyst Upside
+99.9%
Top Competitors
226 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$17.01
|
$2.02B | 48.6 | 51 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$12.69
|
$2.01B | - | 52 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$31.36
|
$1.97B | - | 48 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$8.38
|
$1.92B | - | 49 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$132.18
|
$1.92B | - | 57 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$56.97
|
$1.90B | 334.9 | 58 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$34.35
|
$1.84B | - | 55 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$28.37
|
$1.81B | - | 55 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$4.16
|
$1.78B | - | 51 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$16.54
|
$1.78B | - | 47 | Compare |
More ADMA Analysis
Data updated: May 19, 2026 | Industry: Biotechnology (SIC 2836)
226 stocks in this industry